The Role of Digital Twins in Generic Drug Manufacturing

Digital twins are transforming the pharmaceutical and biopharmaceutical industries by providing real-time monitoring, predictive analytics, and enhancing regulatory compliance for generic drug manufacturing. Digital twins reduce experimentation time and cost, ensure product quality, mitigate waste and enable efficient predictable production. However, implementing them can be complex and requires significant investment in infrastructure and training. Regulatory compliance also poses a challenge.